← 產業報告目錄
Immunology Drugs Market Size, Share & Trends Analysis Report By Drug Class (Monoclonal antibody, Fusion Proteins, Immunosuppressant, Polyclonal antibody, Other Drug Class), By Distribution Channel, By Disease Indications, By Region, And By Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-22頁數 190報告編號 INSIGHTACE-24899400b8
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The global Immunology Drugs Market is anticipated to increase at a compound annual growth rate of 10.5% throughout the 2025–2034 forecast period.
Immunology Drugs encompasses The medical and biological research field known as Immunology Drugs focuses on the immune system. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
Growth is bolstered by a convergence of factors: rising awareness among end users, continuous product innovation, and the growing emphasis on efficiency and sustainability within the healthcare sector.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, bolstered by rapid industrialization and expanding end-user bases.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Immunology Drugs Market Snapshot
Chapter 4. Global Immunology Drugs Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Drug Class Estimates & Trend Analysis
5.1. By Drug Class & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Drug Class:
5.2.1. Monoclonal antibody
5.2.2. Fusion Proteins
5.2.3. Immunosuppressant
5.2.4. Polyclonal antibody
5.2.5. Other Drug Class
Chapter 6. Market Segmentation 2: By Distribution Channel Estimates & Trend Analysis
6.1. By Distribution Channel & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Distribution Channel:
6.2.1. Hospital Pharmacies
6.2.2. Retail Pharmacies
6.2.3. Online Pharmacies
6.2.4. Other Distribution Channel
Chapter 7. Market Segmentation 3: By Disease Indications Estimates & Trend Analysis
7.1. By Disease Indications & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Disease Indications:
7.2.1. Rheumatoid Arthritis
7.2.2. Psoriatic Arthritis
7.2.3. Plaque Psoriasis
7.2.4. Ankylosing Spondylitis
7.2.5. Inflammatory Bowel disease
7.2.6. Other disease Indication
Chapter 8. Immunology Drugs Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Immunology Drugs Market revenue (US$ Million) estimates and forecasts By Drug Class, 2021-2034
8.1.2. North America Immunology Drugs Market revenue (US$ Million) estimates and forecasts By Distribution Channel, 2021-2034
8.1.3. North America Immunology Drugs Market revenue (US$ Million) estimates and forecasts by Disease Indications, 2021-2034
8.1.4. North America Immunology Drugs Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe Immunology Drugs Market revenue (US$ Million) By Drug Class, 2021-2034
8.2.2. Europe Immunology Drugs Market revenue (US$ Million) By Distribution Channel, 2021-2034
8.2.3. Europe Immunology Drugs Market revenue (US$ Million) estimates and forecasts by Disease Indications, 2021-2034
8.2.4. Europe Immunology Drugs Market revenue (US$ Million) by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific Immunology Drugs Market revenue (US$ Million) By Drug Class, 2021-2034
8.3.2. Asia Pacific Immunology Drugs Market revenue (US$ Million) By Distribution Channel, 2021-2034
8.3.3. Asia Pacific Immunology Drugs Market revenue (US$ Million) estimates and forecasts by Disease Indications, 2021-2034
8.3.4. Asia Pacific Immunology Drugs Market revenue (US$ Million) by country, 2021-2034
8.4. Latin America
8.4.1. Latin America Immunology Drugs Market revenue (US$ Million) By Drug Class, 2021-2034
8.4.2. Latin America Immunology Drugs Market revenue (US$ Million) By Distribution Channel, 2021-2034
8.4.3. Latin America Immunology Drugs Market revenue (US$ Million) estimates and forecasts by Disease Indications, 2021-2034
8.4.4. Latin America Immunology Drugs Market revenue (US$ Million) by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Immunology Drugs Market revenue (US$ Million) By Drug Class, 2021-2034
8.5.2. Middle East & Africa Immunology Drugs Market revenue (US$ Million) By Distribution Channel, 2021-2034
8.5.3. Middle East & Africa Immunology Drugs Market revenue (US$ Million) estimates and forecasts by Disease Indications, 2021-2034
8.5.4. Middle East & Africa Immunology Drugs Market revenue (US$ Million) by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Eli Lilly and Company
9.2.2. AbbVie Inc
9.2.3. F.Hoffmann-La roche Ltd
9.2.4. Amgen Inc
9.2.5. Pfizer
9.2.6. Novartis
9.2.7. Astellas
9.2.8. Alector
9.2.9. ImmuNext
9.2.10. Merck sharp & Dohme Corp.
9.2.11. UCB SA
9.2.12. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們